WallStreetZenWallStreetZen

NASDAQ: EFTR
Effector Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for EFTR

Based on 1 analyst offering 12 month price targets for Effector Therapeutics Inc.
Min Forecast
$24.00+1,677.78%
Avg Forecast
$24.00+1,677.78%
Max Forecast
$24.00+1,677.78%

Should I buy or sell EFTR stock?

Based on 1 analyst offering ratings for Effector Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EFTR stock forecasts and price targets.

EFTR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-28

1 of 1

Forecast return on equity

Is EFTR forecast to generate an efficient return?
Company
-1,279.92%
Industry
48.27%
Market
42.03%
EFTR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EFTR forecast to generate an efficient return on assets?
Company
-39.01%
Industry
13.77%
EFTR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EFTR earnings per share forecast

What is EFTR's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$5.63
Avg 2 year Forecast
-$2.25

EFTR revenue forecast

What is EFTR's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$2.2M

EFTR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EFTR$1.35$24.00+1,677.78%Buy
TTNP$6.94N/AN/A
TENX$3.28$30.00+814.63%Strong Buy
HEPA$1.18N/AN/A
CYCN$2.27N/AN/A

Effector Therapeutics Stock Forecast FAQ

Is Effector Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EFTR) stock is to Buy EFTR stock.

Out of 1 analyst, 0 (0%) are recommending EFTR as a Strong Buy, 1 (100%) are recommending EFTR as a Buy, 0 (0%) are recommending EFTR as a Hold, 0 (0%) are recommending EFTR as a Sell, and 0 (0%) are recommending EFTR as a Strong Sell.

If you're new to stock investing, here's how to buy Effector Therapeutics stock.

What is EFTR's earnings growth forecast for 2024-2025?

(NASDAQ: EFTR) Effector Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 18.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.84%.

Effector Therapeutics's earnings in 2024 is -$34,631,000.On average, 2 Wall Street analysts forecast EFTR's earnings for 2024 to be -$26,462,301, with the lowest EFTR earnings forecast at -$29,026,204, and the highest EFTR earnings forecast at -$23,898,398.

In 2025, EFTR is forecast to generate -$10,584,920 in earnings, with the lowest earnings forecast at -$10,584,920 and the highest earnings forecast at -$10,584,920.

What is EFTR's revenue growth forecast for 2025-2025?

(NASDAQ: EFTR) Effector Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 229.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.75%.

Effector Therapeutics's revenue in 2024 is $0.

In 2025, EFTR is forecast to generate $10,349,700 in revenue, with the lowest revenue forecast at $10,349,700 and the highest revenue forecast at $10,349,700.

What is EFTR's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: EFTR) forecast ROA is -39.01%, which is lower than the forecast US Biotechnology industry average of 13.77%.

What is EFTR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EFTR price target, the average EFTR price target is $24.00, with the highest EFTR stock price forecast at $24.00 and the lowest EFTR stock price forecast at $24.00.

The Wall Street analyst predicted that Effector Therapeutics's share price could reach $24.00 by Mar 28, 2025. The average Effector Therapeutics stock price prediction forecasts a potential upside of 1,677.78% from the current EFTR share price of $1.35.

What is EFTR's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: EFTR) Effector Therapeutics's current Earnings Per Share (EPS) is -$12.78. On average, analysts forecast that EFTR's EPS will be -$5.63 for 2024, with the lowest EPS forecast at -$6.17, and the highest EPS forecast at -$5.08. In 2025, EFTR's EPS is forecast to hit -$2.25 (min: -$2.25, max: -$2.25).

What is EFTR's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: EFTR) forecast ROE is -1,279.92%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.